4/A//SEC Filing
Sirtris Pharmaceuticals, Inc. 4/A
Accession 0001179110-08-001471
CIK 0001388775operating
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 4:15 PM ET
Size
7.4 KB
Accession
0001179110-08-001471
Insider Transaction Report
Form 4/AAmended
Jirousek Michael
Senior VP, Research
Transactions
- Award
Incentive Stock Option (Right to buy)
2008-01-02+32,500→ 32,500 totalExercise: $13.00Exp: 2018-01-02→ Common Stock (32,500 underlying) - Award
Common Stock
2008-01-02+32,500→ 32,500 total
Footnotes (1)
- [F1]The options shall vest as to 25% on January 2, 2009, with the remainder to vest in equal quarterly installments over the next 12 quarters ending April 2, July 2, and October 2 following January 2, 2009.
Documents
Issuer
Sirtris Pharmaceuticals, Inc.
CIK 0001388775
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001388775
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 4:15 PM ET
- Size
- 7.4 KB